Starving either the Food and Drug Administration or the National Institutes of Health would be disastrous for the industry, cutting off the flow of new products to the market and the flood of new ideas from academia to industry research labs.
FORBES: A Note to The Pharmaceutical Industry Upon The Re-Election Of Barack Obama